Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...

Peptilogics' PLG0206 is a first-in-class anti-biofilm drug candidate being studied in patients with prosthetic joint infection (PJI), the first of multiple potential medical device-related infections ...

Palm reading may not foresee your future, but if you flip your hand around, it could reveal crucial information about how long you may live.

The neuroendocrine carcinoma market is experiencing steady growth driven by rising disease prevalence and improved diagnostic capabilities. Advancements in targeted therapies and immunotherapies ...

What should oncology nurses and advanced practice providers understand about GLP-1 RAs in the care of patients with breast ...

TD Cowen 46th Annual Health Care Conference March 4, 2026 10:30 AM ESTCompany ParticipantsBrian Sullivan - Co-Founder, Chairman ...

Cardiovascular endocrinology has entered a period of rapid expansion, driven by advances in molecular profiling, translational therapeutics, and integrative ...